期刊文献+

肺癌细胞抑癌蛋白PTEN下调机制的研究 被引量:3

Mechanisms of PTEN down-regulation in lung cancer cells
原文传递
导出
摘要 目的:探讨肺癌细胞中抑癌蛋白PTEN低表达的相关机制。方法:Western blot方法检测肺癌细胞和正常人肺上皮细胞BEAS-2BPTEN蛋白的表达;用放线菌酮(1μg/mL)处理人肺腺癌细胞A549和正常人肺上皮细胞BEAS-2B阻断细胞翻译后,Western blot方法检测不同时相PTEN蛋白的表达。RT-PCR检测肺癌细胞与正常肺上皮细胞PTEN mRNA水平;放线菌素D(1μg/mL)处理肺癌细胞与正常肺上皮细胞阻断新生RNA合成,RT-PCR检测不同时相PTEN mRNA的水平。结果:Western blot结果显示,肺癌细胞中PTEN蛋白表达与正常肺上皮细胞比较有不同程度的降低(0.38~1.32倍);使用放线菌酮处理A549和BEAS-2B后,24h内A549及BEAS-2B细胞PTEN蛋白表达无明显改变。RT-PCR结果显示肺癌细胞中PTEN mRNA与正常人肺上皮细胞相比明显降低(0.41~0.68倍);放线菌素D处理显示肺癌细胞PTEN mRNA降解速率比正常肺上皮细胞降解速率明显加快。结论:肺癌细胞中抑癌蛋白PTEN低表达的主要原因是其mRNA降解加速,这为进一步研究PTEN蛋白低表达的详细分子机制提供了线索。 OBJECTIVE:To investigate the mechanisms of low expression of PTEN in lung cancer ceils. METHODS: Western blot was performed to detect the protein expression of PTEN in lung cancer cells and normal human lung epithelial cell. After translation inhibition with cycloheximide (1 μg/mL), PTEN protein levels were determined during different phases. The levels of PTEN mRNA were determined by RT-PCR in A549 and BEAS-2B. Then, the treatment of actinomycin D (1 μg/mL) for blocking transcription, evaluated PTEN mRNA at indicated time point in A549 and BEAS-2B cells. RESULTS: Western blot showed that the PTEN protein was obviously decreased by approximately 0. 38- 1.32 times in lung cancer cells than normal lung ceil. After using cycloheximide, PTEN protein expression in A549 had not changed significantly during 24 hours as well as BEAS-2B. RT-PCR results showed that PTEN mRNA levels were significantly dropped by 0.41-0.68 times in lung cancer cells, compared with BEAS-2B. The treatment with actinomycin D, PTEN mRNA degradation rate in lung cancer cells was much faster than that in BEAS-2B. CONCLUSION: These data indicates that PTEN mRNA degradation acceleration led to down-regulation of PTEN, which provids some clues for further investigating the PTEN expression molecular mechanisms in lung cancer cells.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第6期419-422,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 上海市科学技术委员会基金(10JC1409200) 上海市宝山区科委基金(10-E-3)
关键词 肺肿瘤 抑癌蛋白 PTEN 基因表达 分子机制 lung neoplasms tumor suppressor protein PTEN gene expression molecular mechanism
  • 相关文献

参考文献4

二级参考文献56

  • 1陈颖,赵雨杰,郑华川,杨雪飞,张淑兰,辛彦.PTEN与VEGF_(165)基因mRNA在卵巢癌中表达及相关性研究[J].肿瘤防治杂志,2003,10(12):1244-1247. 被引量:1
  • 2周蔚,李留霞.卵巢癌的靶向基因治疗研究进展[J].国外医学(妇产科学分册),2006,33(5):324-327. 被引量:3
  • 3魏法才,陈启,杨道贵,隋永领.胃癌组织中PTEN和VEGF的表达及其相关性[J].中华肿瘤防治杂志,2007,14(8):601-603. 被引量:9
  • 4李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 5Sohn D M, Kim S Y, Baek M J, et al. Expression of survivin and clinical correlation in patients with breast cancer[J]. Biomed Pharmacother,2006,60(6): 289-292.
  • 6Lee J S, Kim H S, Kim Y B, et al. Reduced PTEN expression is associated with poor outcome and angiogenesis in invasive duc- tal carcinoma of the breast[J]. Appl Immunohistochem Mol Morphol, 2004,12(3) : 205-210.
  • 7Zhu L, Loo W T Y, Louis W C C, et al. PTEN and VEGF.-Possible predictors for sentinel lymph node micro-metastasis in breast cancer [J]. Biomed Pharmacother, 2007,61(9) : 558-561.
  • 8Saal L H, Johansson P, Holm K, et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity[J]. PNAS, 2007,104 (18) : 7564-7569.
  • 9Tsutsui S, lnoue H, Yasuda K, et al. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast[J]. Oncology, 2005,68(4-6) : 398-404.
  • 10Faratian D, Bartlett J. Predictive markers in breast cancer the future[J. Histopathology, 2008,52(1): 91-98.

共引文献153

同被引文献49

  • 1张秋金,沈洪,张维,李银平,黎檀实.纳洛酮与甲基泼尼松龙联用对急性肺损伤大鼠肺组织核转录因子-κB表达的影响[J].中国危重病急救医学,2005,17(6):370-372. 被引量:33
  • 2张少青,雷清.丹东市区1998—2004年恶性肿瘤死亡情况分析[J].中国慢性病预防与控制,2006,14(3):198-199. 被引量:15
  • 3Weiss J,Sos ML,Seidel D,et al. Frequent and focal FGFR1 am- plification associates with therapeutically tractable FGFR] de- pendency in squamous cell lung cancer [J]. Sei Transl Med, 2010,2(62) : 62ra93.
  • 4Schildhaus HU, Heukamp LC, Merkelbach-Bruse S, et al. Defi- nition of a fluorescence in-situ hybridization score identifies high- and lowqevel FGFR1 amplification types in squamous cell lung cancer[J]. Mod Pathol,2012,25(ll) :1473-1480.
  • 5Reck M, Kaiser R, Eschbach C, et al. A phase H double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed ad- vanced non-small-cell lung caneer[J] Ann Oneol, 2011,22 (6) : 1374 1381.
  • 6Nakagawa M, Uramoto H,Oka S, et al. Clinical significance of IGF1R expression in non-small-cell lung eancer[J]. Clin LungCancer,2012,13(2) : 136-142.
  • 7Ludovini V, Bellezza G, Pistola L, et al. High coexpression of both insulin-like growth factor receptor-I (IGFR-1) and epider- mal growth factor receptor (EGFR) is associated with shorter disease free survival in resected non-small-cell lung cancer pa- tients[J]. Ann Oncol, 2009,20 (5) : 842-849.
  • 8Karp DD,Paz-Ares LG,Novello S,et al. Phase ]1 study of the anti-insulin-like growth factor type 1 receptor antibody CP-751, 871 in combination with paclitaxel and earboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer{J]. J Clin Oncol,2009,27(15) :2516-2522.
  • 9Ji H,Zhao X,Yuza Y,et al. Epidermal growth factor receptor variant llI mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors[J]. Proc Natl Acad Sci U S A, 2006, 103(20) :7817-7822.
  • 10Uribe P,Gonzalez S. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin,molecular bases for EG- FR-targeted therapy. [J]. Pathol Res Pract, 2011,207 (6) : 337- 342.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部